NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Cheilbio Co. Ltd (KQ: 052670)
052670 Technical Analysis
2
As on 20th Jul 2023 052670 STOCK Price closed @ 2080.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1954.87 & Strong Sell for SHORT-TERM with Stoploss of 2580.45 we also expect STOCK to react on Following IMPORTANT LEVELS. |
052670STOCK Price
Open | 2345.00 | Change | Price | % |
High | 2345.00 | 1 Day | -230.00 | -9.96 |
Low | 2055.00 | 1 Week | 160.00 | 8.33 |
Close | 2080.00 | 1 Month | 82.00 | 4.10 |
Volume | N/A | 1 Year | -465.00 | -18.27 |
52 Week High 2895.00 | 52 Week Low 1153.00 |
KQ Korea Most Active Stocks
001470 | 1274.00 | 30.00% |
001470 | 1274.00 | 30.00% |
082850 | 3320.00 | 5.73% |
009810 | 345.00 | 14.24% |
009810 | 345.00 | 14.24% |
030530 | 2870.00 | 6.69% |
217730 | 2685.00 | 18.81% |
000040 | 670.00 | 12.42% |
000040 | 670.00 | 12.42% |
214870 | 1383.00 | -27.44% |
KQ Korea Top Gainers Stocks
KQ Korea Top Losers Stocks
052670 Daily Charts |
052670 Intraday Charts |
Whats New @ Bazaartrend |
052670 Free Analysis |
|
052670 Important Levels Intraday
RESISTANCE | 2638.83 |
RESISTANCE | 2459.61 |
RESISTANCE | 2348.83 |
RESISTANCE | 2238.05 |
SUPPORT | 1921.95 |
SUPPORT | 1811.17 |
SUPPORT | 1700.39 |
SUPPORT | 1521.17 |
052670 Forecast November 2024
4th UP Forecast | 3457.81 |
3rd UP Forecast | 3015.94 |
2nd UP Forecast | 2742.81 |
1st UP Forecast | 2469.68 |
1st DOWN Forecast | 1690.33 |
2nd DOWN Forecast | 1417.2 |
3rd DOWN Forecast | 1144.07 |
4th DOWN Forecast | 702.2 |
052670 Weekly Forecast
4th UP Forecast | 2870.07 |
3rd UP Forecast | 2616.69 |
2nd UP Forecast | 2460.07 |
1st UP Forecast | 2303.45 |
1st DOWN Forecast | 1856.55 |
2nd DOWN Forecast | 1699.93 |
3rd DOWN Forecast | 1543.31 |
4th DOWN Forecast | 1289.93 |
052670 Forecast2024
4th UP Forecast | 5787.55 |
3rd UP Forecast | 4598.52 |
2nd UP Forecast | 3863.55 |
1st UP Forecast | 3128.58 |
1st DOWN Forecast | 1031.42 |
2nd DOWN Forecast | 296.45 |
3rd DOWN Forecast | -438.52 |
4th DOWN Forecast | -1627.55 |
Cheilbio Co. Ltd ( KQ Korea Symbol : 052670 )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
052670 Other Details
Segment | EQ | |
Market Capital | 52650000384.00 | |
Sector | ||
Industry | ||
Offical website | > echo $website ; ?> |
052670 Address
052670 Latest News
052670 Business Profile
Cheilbio Co., Ltd. produces and sells veterinary products for pig, cattle, chicken, aqua, and other animals in South Korea. The company is also involved in the farm disease consulting, such as differentiation of disease and detection of pathogen; development and production of ELISA diagnostic kits; and development instant rapid kits. In addition, it offers raw materials for veterinary pharmaceuticals, fermentation and feed additives ingredients, and feed additives. The company was formerly known as Jeil Chemical Co. and changed its name to Cheilbio Co., Ltd. in 2000. Cheilbio Co., Ltd. was founded in 1977 and is headquartered in Yongin, South Korea. Address: #1601, 767 Sinsu-ro, Yongin, South Korea, 16827
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service